Hormone Therapy News

DENVER — Bilateral oophorectomy was common during gender-affirming hysterectomy and associated with younger age, prior testosterone use and male identity, according to study results presented at the ASRM Scientific Congress & Expo.

DENVER — Exposure to testosterone therapy did not impact outcomes related to egg freezing for transgender men who sought fertility preservation treatment, researchers reported.

Prior testosterone exposure did not impact oocyte cryopreservation outcomes among transgender and gender-diverse adolescents and young adults, according to a research letter published in Obstetrics & Gynecology.

Hormone therapy use markedly declined among postmenopausal women of all ages, races and ethnicities in the U.S. during the past 2 decades, according to findings published in JAMA Health Forum.

CHICAGO — In this Healio video exclusive, Pauline M. Maki, PhD, provides three takeaways from her talk on cognition and hormone therapy during menopause at the Annual Meeting of The Menopause Society.

CHICAGO — Voice and respiratory changes can impact women’s health during menopause and hormone therapy plays a role in helping or worsening these changes, according to a speaker at the Annual Meeting of The Menopause Society.

CHICAGO — Hormone therapy is beneficial for some women beyond age 65 years to treat ongoing menopausal symptoms that affect their quality of life, according to research reported at the Annual Meeting of The Menopause Society.

Vaginal estrogen, vaginal dehydroepiandrosterone, oral ospemifene and vaginal moisturizers result in short-term improvements in vaginal atrophy symptoms, known as genitourinary syndrome of menopause, but more long-term data are needed.

Postmenopausal women with a history of hormone therapy use were biologically younger compared with never-using counterparts, regardless of socioeconomic background, according to study results published in JAMA Network Open.